WO2001038580A3 - Nucleic acid probe arrays - Google Patents

Nucleic acid probe arrays Download PDF

Info

Publication number
WO2001038580A3
WO2001038580A3 PCT/US2000/032131 US0032131W WO0138580A3 WO 2001038580 A3 WO2001038580 A3 WO 2001038580A3 US 0032131 W US0032131 W US 0032131W WO 0138580 A3 WO0138580 A3 WO 0138580A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
anchor primer
array
target nucleic
acid
Prior art date
Application number
PCT/US2000/032131
Other languages
French (fr)
Other versions
WO2001038580A9 (en
WO2001038580A2 (en
Inventor
Jonathan M Rothberg
Joel S Bader
Original Assignee
Curagen Corp
Jonathan M Rothberg
Joel S Bader
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Jonathan M Rothberg, Joel S Bader filed Critical Curagen Corp
Priority to AU17927/01A priority Critical patent/AU783841B2/en
Priority to CA002392474A priority patent/CA2392474A1/en
Priority to JP2001539921A priority patent/JP2003515149A/en
Priority to EP00980700A priority patent/EP1234058A2/en
Publication of WO2001038580A2 publication Critical patent/WO2001038580A2/en
Publication of WO2001038580A3 publication Critical patent/WO2001038580A3/en
Publication of WO2001038580A9 publication Critical patent/WO2001038580A9/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/682—Signal amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Abstract

Disclosed are nucleic acid probe arrays and methods of identifying and sequencing nucleic acids in a population of nucleic acids using the arrays. The method is preferably performed by annealing a nucleic acid template to an anchor primer attached to a durface of the array. At least one anchor in the array has a sequence complementary to sequences at the 5' and 3' termini of a target nucleic acid.The annealed linear target nucleic acid is circularized using one or two ligation reactions. In one embodiment, one liggation is issued. Annealing of of the linear nucleic acid results in juxtaposition of the 5' and 3' termini of the target nucleic acid on the anchor primer. Addition of a ligase results in circulization of the target nucleic acid. This circularized nucleic acid is a template for extension of the anchor primer in a rolling circle amplification reaction. An extended anchor primer containing multiple copies of a sequence complementary to the circular mucleic acid is also referred to herein as a anchor primer nucleid acid-nucleic acid concatamer. The presence of multiple copies of the complementary sequence facilitates detection of the nucleic acid. Thus, the method provides for a highly sensitive method of detecting a desired nucleic acid attached at a discrete location on the array.
PCT/US2000/032131 1999-11-26 2000-11-27 Nucleic acid probe arrays WO2001038580A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU17927/01A AU783841B2 (en) 1999-11-26 2000-11-27 Nucleic acid probe arrays
CA002392474A CA2392474A1 (en) 1999-11-26 2000-11-27 Nucleic acid probe arrays
JP2001539921A JP2003515149A (en) 1999-11-26 2000-11-27 Nucleic acid probe array
EP00980700A EP1234058A2 (en) 1999-11-26 2000-11-27 Nucleic acid probe arrays

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44940299A 1999-11-26 1999-11-26
US09/449,402 1999-11-26

Publications (3)

Publication Number Publication Date
WO2001038580A2 WO2001038580A2 (en) 2001-05-31
WO2001038580A3 true WO2001038580A3 (en) 2002-04-25
WO2001038580A9 WO2001038580A9 (en) 2002-12-05

Family

ID=23784034

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/032131 WO2001038580A2 (en) 1999-11-26 2000-11-27 Nucleic acid probe arrays

Country Status (5)

Country Link
EP (1) EP1234058A2 (en)
JP (1) JP2003515149A (en)
AU (1) AU783841B2 (en)
CA (1) CA2392474A1 (en)
WO (1) WO2001038580A2 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2378245A (en) 2001-08-03 2003-02-05 Mats Nilsson Nucleic acid amplification method
US9388459B2 (en) * 2002-06-17 2016-07-12 Affymetrix, Inc. Methods for genotyping
US9487823B2 (en) 2002-12-20 2016-11-08 Qiagen Gmbh Nucleic acid amplification
US6977153B2 (en) * 2002-12-31 2005-12-20 Qiagen Gmbh Rolling circle amplification of RNA
EP1598427A1 (en) * 2004-05-17 2005-11-23 Charité - Universitätsmedizin Berlin Method for the amplification of a target nucleic acid
AU2005250432B2 (en) 2004-05-28 2011-09-15 Asuragen, Inc. Methods and compositions involving microRNA
ES2534304T3 (en) 2004-11-12 2015-04-21 Asuragen, Inc. Procedures and compositions involving miRNA and miRNA inhibitor molecules
CA2611671C (en) 2005-06-15 2013-10-08 Callida Genomics, Inc. Single molecule arrays for genetic and chemical analysis
EP1762627A1 (en) 2005-09-09 2007-03-14 Qiagen GmbH Method for the activation of a nucleic acid for performing a polymerase reaction
US11306351B2 (en) 2005-12-21 2022-04-19 Affymetrix, Inc. Methods for genotyping
WO2008036776A2 (en) 2006-09-19 2008-03-27 Asuragen, Inc. Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
JP5520605B2 (en) 2006-09-19 2014-06-11 アシュラジェン インコーポレイテッド MicroRNA differentially expressed in pancreatic diseases and uses thereof
BRPI0812461A2 (en) 2007-06-08 2017-06-13 Biogen Idec Inc method of predicting an individual's response to therapy, method of treating an immune disorder, composition and kit
JP5020734B2 (en) * 2007-07-31 2012-09-05 株式会社日立ハイテクノロジーズ Nucleic acid analysis method and apparatus
EP2285960B1 (en) 2008-05-08 2015-07-08 Asuragen, INC. Compositions and methods related to mir-184 modulation of neovascularization or angiogenesis
US8486630B2 (en) 2008-11-07 2013-07-16 Industrial Technology Research Institute Methods for accurate sequence data and modified base position determination
GB0921264D0 (en) 2009-12-03 2010-01-20 Olink Genomics Ab Method for amplification of target nucleic acid
US10273544B2 (en) 2010-02-11 2019-04-30 Dana-Farber Cancer Institute, Inc. Methods for predicting likelihood of responding to treatment
ES2631458T3 (en) 2010-03-04 2017-08-31 Interna Technologies B.V. MRNA molecule defined by its source and its therapeutic uses in cancer associated with EMT
EP2591106A1 (en) 2010-07-06 2013-05-15 InteRNA Technologies B.V. Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
EP2772550B1 (en) 2010-11-17 2017-03-29 Interpace Diagnostics, LLC Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms
EP2474617A1 (en) 2011-01-11 2012-07-11 InteRNA Technologies BV Mir for treating neo-angiogenesis
EP2681566A2 (en) 2011-02-28 2014-01-08 University of Iowa Research Foundation Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender
CN102732598B (en) * 2011-04-11 2017-03-01 陈先锋 A kind of complete genome DNA sequence assembly sequence measurement
WO2012168803A2 (en) 2011-06-07 2012-12-13 Koninklijke Philips Electronics N.V. Providing nucleotide sequence data
US9644241B2 (en) 2011-09-13 2017-05-09 Interpace Diagnostics, Llc Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
US20130157884A1 (en) 2011-10-26 2013-06-20 Asuragen, Inc. Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
EP2771487A1 (en) 2011-10-27 2014-09-03 Asuragen, INC. Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
EP2870263A1 (en) 2012-07-03 2015-05-13 InteRNA Technologies B.V. Diagnostic portfolio and its uses
US20140100124A1 (en) 2012-10-04 2014-04-10 Asuragen, Inc. Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
KR101984700B1 (en) * 2012-11-19 2019-05-31 삼성전자주식회사 Polynucleotide and use thereof
EP3404116B1 (en) 2013-03-15 2022-10-19 The University of Chicago Methods and compositions related to t-cell activity
US9758835B2 (en) 2013-03-15 2017-09-12 Baylor Research Institute Ulcerative colitis (UC)-associated colorectal neoplasia markers
CA2907377A1 (en) 2013-03-15 2014-09-18 Baylor Research Institute Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
US11859246B2 (en) * 2013-12-11 2024-01-02 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
US11286519B2 (en) 2013-12-11 2022-03-29 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
AU2014362227B2 (en) * 2013-12-11 2021-05-13 Accuragen Holdings Limited Compositions and methods for detecting rare sequence variants
US20180119221A1 (en) 2015-04-02 2018-05-03 Hmnc Value Gmbh Method of Treatment Using Genetic Predictors of a Response to Treatment with CRHR1 Antagonists
JP7008016B2 (en) 2015-10-09 2022-01-25 アキュラジェン ホールディングス リミテッド Methods and Compositions for Enriching Amplified Products
JPWO2017135383A1 (en) * 2016-02-03 2018-12-06 国立大学法人豊橋技術科学大学 Pseudocyclic double-stranded polynucleotide and gene expression inhibitor using the same
WO2017201102A1 (en) 2016-05-16 2017-11-23 Accuragen Holdings Limited Method of improved sequencing by strand identification
CA3033749A1 (en) 2016-08-15 2018-02-22 Accuragen Holdings Limited Compositions and methods for detecting rare sequence variants
US20190309352A1 (en) * 2016-11-16 2019-10-10 Progenity, Inc Multimodal assay for detecting nucleic acid aberrations
WO2019086603A1 (en) 2017-11-03 2019-05-09 Interna Technologies B.V. Mirna molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
US11203782B2 (en) 2018-03-29 2021-12-21 Accuragen Holdings Limited Compositions and methods comprising asymmetric barcoding
EP3952849A4 (en) 2019-04-12 2023-03-01 The Regents Of The University Of California Compositions and methods for increasing muscle mass and oxidative metabolism
WO2024028794A1 (en) 2022-08-02 2024-02-08 Temple Therapeutics BV Methods for treating endometrial and ovarian hyperproliferative disorders

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854033A (en) * 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
WO1999049079A1 (en) * 1998-03-25 1999-09-30 Ulf Landegren Rolling circle replication of padlock probes
WO1999053102A1 (en) * 1998-04-16 1999-10-21 Packard Bioscience Company Analysis of polynucleotide sequence

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5503980A (en) * 1992-11-06 1996-04-02 Trustees Of Boston University Positional sequencing by hybridization
SE9701783D0 (en) * 1997-05-14 1997-05-14 Marek Kwiatkowski In situ synthesis of oligonucleotides or inverse orientation
US6280954B1 (en) * 1998-02-02 2001-08-28 Amersham Pharmacia Biotech Ab Arrayed primer extension technique for nucleic acid analysis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854033A (en) * 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
WO1999049079A1 (en) * 1998-03-25 1999-09-30 Ulf Landegren Rolling circle replication of padlock probes
WO1999053102A1 (en) * 1998-04-16 1999-10-21 Packard Bioscience Company Analysis of polynucleotide sequence

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HATCH A ET AL: "Rolling circle amplification of DNA immobilized on solid surfaces and its application to multiplex mutation detection", GENETIC ANALYSIS: BIOMOLECULAR ENGINEERING,ELSEVIER SCIENCE PUBLISHING,US, vol. 15, no. 2, April 1999 (1999-04-01), pages 35 - 40, XP004223009, ISSN: 1050-3862 *
LIZARDI P M ET AL: "MUTATION DETECTION AND SINGLE-MOLECULE COUNTING USING ISOTHERMAL ROLLING-CIRCLE AMPLIFICATION", NATURE GENETICS,US,NEW YORK, NY, vol. 19, no. 3, July 1998 (1998-07-01), pages 225 - 232, XP000856939, ISSN: 1061-4036 *
See also references of EP1234058A2 *

Also Published As

Publication number Publication date
AU783841B2 (en) 2005-12-15
WO2001038580A9 (en) 2002-12-05
WO2001038580A2 (en) 2001-05-31
EP1234058A2 (en) 2002-08-28
CA2392474A1 (en) 2001-05-31
AU1792701A (en) 2001-06-04
JP2003515149A (en) 2003-04-22

Similar Documents

Publication Publication Date Title
WO2001038580A3 (en) Nucleic acid probe arrays
WO2001020039A3 (en) Method of sequencing a nucleic acid
EP2308997A3 (en) Detection of nucleic acids by type-specific hybrid capture method
WO1999005315A3 (en) Nucleic acid sequence analysis
AU2001284295A1 (en) Method of sequencing dna
EP0664339A4 (en) Method of discriminating nucleic acid and testing set for discriminating nucleic acid.
WO2001077372A3 (en) Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
CA2244891A1 (en) Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
WO1998002582A3 (en) Methods for detecting and amplifying nucleic acid sequences using modified oligonucleotides having increased target specific t¿m?
AU1502395A (en) Detection of nucleic acid amplification
EP1634966A3 (en) Methods for detection of nucleic acid sequences in urine
AU2096192A (en) Mycobacterium primers and probes
WO2005066370A3 (en) Methods for determining nucleotide sequence information
ATE188745T1 (en) METHOD FOR DETECTING A NUCLIC ACID USING A NUCLIC ACID PROBE WHICH ALLOWS SPECIFIC CAPTURE AND DETECTION AT ONCE
WO2002048402A3 (en) Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
WO2002057491A3 (en) Direct multiplex characterization of genomic dna
EP0718408A3 (en) Sensitive method for detecting nucleic acids
WO2004059289A3 (en) Target-dependent transcription using deletion mutants of n4 rna polymerase
BR9606602A (en) Oligonucleotide amplification primer and method for complex complex amplification of an acid
WO2003083137A3 (en) Detection of circularized immobilized nucleic acid probes
WO2004027081A3 (en) Methods and composition for detecting targets
EP0682121A4 (en) Method of amplifying and detecting target nucleic acid sequence by using thermostable enzymes.
WO1996015264A3 (en) Method for identifying nucleic acid sequences from different biological sources through amplification of the same
EP0950718A4 (en) Method for detecting dna with probe pna
WO2005060618A3 (en) Enzyme-free isothermal exponential amplification of nucleic acids and nucleic acid analog signals

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2392474

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 539921

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 17927/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000980700

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000980700

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWG Wipo information: grant in national office

Ref document number: 17927/01

Country of ref document: AU